What is IPCL (Implantable Phakic Contact Lens) and what does it do?

IPCL is a treatment method that corrects myopia and astigmatism by inserting a small lens into the eye.

What material is used to make the implantable contact lens IPCL?

It uses an acrylic polymer material primarily composed of HEMA, which is widely used in intraocular lenses.

How does the reversibility of IPCL treatment compare to LASIK?

Unlike LASIK, it does not involve shaving the cornea, making it a highly reversible treatment as the lens can be removed.

What were the survey results regarding awareness and interest in implantable contact lenses?

More than 70% (72.8%) of the survey subjects were aware of it, and about 70% (71.9%) were interested in it.

AI News NQ Analysis

Survey on Awareness of Implantable Contact Lenses (Phakic Posterior Chamber Lenses) Among Men and Women in Their 20s-40s with Vision of 0.1 or Less

NQ Score 50/100

AI Summary (NQ-processed)

At Working Co., Ltd., the Japanese distributor of "IPCL®," an implantable contact lens approved by the Ministry of Health, Labour and Welfare in April 2025, conducted a survey on implantable contact lenses among men and women in their 20s to 40s nationwide. The survey found that over 70% of respondents were aware of the treatment, with nearly the same percentage expressing interest. The primary drivers of interest were the inconvenience and ongoing cost of glasses and traditional contact lenses, while the main deterrents were fear of surgery and safety concerns. Interest was notably higher among women in their 20s and 30s.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is IPCL (Implantable Phakic Contact Lens) and what does it do?: A: IPCL is a treatment method that corrects myopia and astigmatism by inserting a small lens into the eye.
Q: What material is used to make the implantable contact lens IPCL?: A: It uses an acrylic polymer material primarily composed of HEMA, which is widely used in intraocular lenses.
Q: How does the reversibility of IPCL treatment compare to LASIK?: A: Unlike LASIK, it does not involve shaving the cornea, making it a highly reversible treatment as the lens can be removed.
Q: When did IPCL obtain regulatory approval and launch in Japan?: A: It obtained regulatory approval from the Ministry of Health, Labour and Welfare in April 2025 and launched in September of the same year.
Q: What were the survey results regarding awareness and interest in implantable contact lenses?: A: More than 70% (72.8%) of the survey subjects were aware of it, and about 70% (71.9%) were interested in it.